captopril has been researched along with vitamin k 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hu, Z; Li, M; Li, S; Shao, J; Wang, Z; Xia, H; Yu, L | 1 |
1 review(s) available for captopril and vitamin k 1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for captopril and vitamin k 1
| Article | Year |
|---|---|
Captopril Attenuates the Upregulated Connexin 43 Expression in Artery Calcification.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atherosclerosis; Calcium-Binding Proteins; Captopril; Connexin 43; Down-Regulation; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Male; Matrix Gla Protein; Microfilament Proteins; Muscle Proteins; RANK Ligand; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Up-Regulation; Vascular Calcification; Vascular Stiffness; Vitamin K 1; Warfarin | 2020 |